All translations
Jump to navigation
Jump to search
Enter a message name below to show all available translations.
Found 2 translations.
| Name | Current message text |
|---|---|
| h English (en) | NMN is a precursor for [[Nicotinamide adenine dinucleotide|NAD<sup>+</sup>]] biosynthesis, and NMN dietary supplementation has been demonstrated to increase NAD<sup>+</sup> concentration and thus has the potential to mitigate aging-related disorders such as [[oxidative stress]], [[DNA damage (naturally occurring)|DNA damage]], [[Neurodegenerative disease|neurodegeneration]] and [[inflammation|inflammatory responses]]. Song Q, Zhou X, Xu K, Liu S, Zhu X, Yang J. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update. Adv Nutr. 2023 Nov;14(6):1416-1435. doi: 10.1016/j.advnut.2023.08.008. Epub 2023 Aug 22. PMID: 37619764; PMCID: PMC10721522</ref> The potential benefits and risks of NMN supplementation, as of 2023, are currently under investigation. |
| h Japanese (ja) | NMNは[[Nicotinamide adenine dinucleotide/ja|NAD<sup>+</sup>]]生合成の前駆体であり、NMNの栄養補助食品はNAD<sup>+</sup>濃度を増加させることが実証されているため、[[oxidative stress/ja|酸化ストレス]]、[[DNA damage (naturally occurring)/ja|DNA損傷]]、[[Neurodegenerative disease/ja|神経変性]]、[[inflammation/ja|炎症反応]]などの老化関連障害を緩和する可能性がある。宋Q、周X、徐K、劉S、朱X、楊J. ヒト臨床試験におけるニコチンアミドモノヌクレオチドの安全性と抗老化効果：最新情報。2023 Nov;14(6):1416-1435. doi: 10.1016/j.advnut.2023.08.008. Epub 2023 Aug 22. PMID: 37619764; PMCID: PMC10721522</ref> 2023年現在、NMN補給の潜在的なベネフィットとリスクは現在調査中である。 |